UOC
RBOT

UBS O'Connor’s Vicarious Surgical RBOT Stock Holding History

UBS O'Connor’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,417
Closed -$723K – 978
2021
Q2 		$723K Sell
2,417
-14,249
-85% -$4.24M 0.01% 586
2021
Q1 		$4.97M Sell
16,666
-12,230
-42% -$3.74M 0.07% 217
2020
Q4 		$8.81M Buy
+28,896
New +$8.49M 0.18% 96

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

UBS O'Connor's RBOT Position: Q3 2021 in Review

UBS O'Connor sold out of Vicarious Surgical (RBOT) in Q3 2021, closing a stake of 2,417 shares — an estimated $723K sold.

UBS O'Connor first reported a position in RBOT in Q4 2020 and held it in 3 quarters. The position peaked at $8.81M in Q4 2020. 35 funds tracked by Wall St. Rank hold RBOT as of Q3 2021.

  • UBS O'Connor reported no remaining Vicarious Surgical position as of Q3 2021 after selling out during the quarter.
  • UBS O'Connor sold 2,417 Vicarious Surgical shares in Q3 2021, an estimated $723K.
  • UBS O'Connor first reported a position in Vicarious Surgical in Q4 2020 and held it in 3 quarters.
  • UBS O'Connor's Vicarious Surgical position peaked at $8.81M in Q4 2020.
  • 35 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2021.

Based on UBS O'Connor's 13F filing for Q3 2021, filed 12 Nov 2021.